Welcome to LookChem.com Sign In|Join Free

CAS

  • or

505088-49-3

Methyl 1-(2,2-diMethylpropanoyl)piperidine-4-carboxylate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

505088-49-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 505088-49-3 Structure

  • Basic information

    1. Product Name: Methyl 1-(2,2-diMethylpropanoyl)piperidine-4-carboxylate
    2. Synonyms: Methyl 1-(2,2-diMethylpropanoyl)piperidine-4-carboxylate
    3. CAS NO:505088-49-3
    4. Molecular Formula: C12H21NO3
    5. Molecular Weight: 227.30004
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 505088-49-3.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: Methyl 1-(2,2-diMethylpropanoyl)piperidine-4-carboxylate(CAS DataBase Reference)
    10. NIST Chemistry Reference: Methyl 1-(2,2-diMethylpropanoyl)piperidine-4-carboxylate(505088-49-3)
    11. EPA Substance Registry System: Methyl 1-(2,2-diMethylpropanoyl)piperidine-4-carboxylate(505088-49-3)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 505088-49-3(Hazardous Substances Data)

505088-49-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 505088-49-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,5,0,8 and 8 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 505088-49:
(8*5)+(7*0)+(6*5)+(5*0)+(4*8)+(3*8)+(2*4)+(1*9)=143
143 % 10 = 3
So 505088-49-3 is a valid CAS Registry Number.

505088-49-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 1-(2,2-dimethylpropanoyl)piperidine-4-carboxylate

1.2 Other means of identification

Product number -
Other names Methyl 1-pivaloylpiperidine-4-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:505088-49-3 SDS

505088-49-3Downstream Products

505088-49-3Relevant articles and documents

Silver-Catalyzed Site-Selective Ring-Opening and C-C Bond Functionalization of Cyclic Amines: Access to Distal Aminoalkyl-Substituted Quinones

Liu, Rui-Hua,He, Yi-Heng,Yu, Wei,Zhou, Bo,Han, Bing

, p. 4590 - 4594 (2019)

Distal aminoalkyl-substituted quinones have been efficiently prepared through silver-catalyzed site-selective deconstruction and C-C bond transformation of unstrained N-acylated cyclic amines. This method enjoys mild reaction conditions, high selectivity, a broad scope of substrates, and a low catalytic loading of silver. This strategy can also be applied to the modification of peptides bearing cyclic amine residues.

FUSED IMIDAZOLE DERIVATIVES USEFUL AS IDO INHIBITORS

-

Page/Page column 100, (2012/11/06)

Presently provided are IDO inhibitors and pharmaceutical compositions thereof, useful for modulating an activity of indoleamine 2,3-dioxygenase; treating indoleamine 2,3-dioxygenase (IDO) mediated inimunosuppression; treating a medical conditions that benefit from the inhibition of enzymatic activity of indoleamine-2,3-dioxygenase; enhancing the effectiveness of an anti-cancer treatment comprising administering an anti-cancer agent; treating tumor-specific immunosuppression associated with cancer; and treating immunosupression associated with an infectious disease.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 505088-49-3